Stephen V Liu, MD (@stephenvliu) 's Twitter Profile
Stephen V Liu, MD

@stephenvliu

Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25 #DCLung25; #HereWeGo

ID: 377425889

linkhttps://www.medstarhealth.org/doctors/stephen-liu-md calendar_today21-09-2011 15:17:53

19,19K Tweet

26,26K Takipçi

3,3K Takip Edilen

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo
Stephen V Liu, MD
@stephenvliu

3 months ago

Dr. Li Zhang at #ASCO25 with Opti-TROP-Lung03 with sacituzumab tirumotecan (Sac-TMT) in EGFR NSCLC post TKI and chemo randomized vs docetaxel. Sac-TMT superior: RR 45% vs 16%, PFS 6.9 vs 2.8m HR 0.30, OS immature but HR 0.49 (HR 0.36 adjusted for crossover). Approved in China.

Dr. Li Zhang at #ASCO25 with Opti-TROP-Lung03 with sacituzumab tirumotecan (Sac-TMT) in EGFR NSCLC post TKI and chemo randomized vs docetaxel. Sac-TMT superior: RR 45% vs 16%, PFS 6.9 vs 2.8m HR 0.30, OS immature but HR 0.49 (HR 0.36 adjusted for crossover). Approved in China.